Neurodevelopmental Effects of Antiepileptic Drugs (NEAD)

Coordinating Center
Project Status
Active
Project Lifespan
09/30/1999
Objective

Researchers want to determine what impact carbamazepine (TegretolR, Tegretol-XRR, CarbatrolR), lamotrigine (LamictalR), phenytoin (DilantinR), and valproate (DepakoteR) have on the children’s ability to think and learn.

Population

Three hundred and thirty women and their children in the US and England taking one of the four most commonly prescribed anti-seizure medications. The mothers and children are followed from their first trimester until their children are several years old.

Centers

25

Additional Information

The primary objective of the NEAD study is to differentiate the relative risks and benefits of the 4 most commonly used AEDs (Carbamazepine, lamotrigine, phenytoin, or valproate) in women of childbearing age in terms of their children’s neurobehavioral outcomes. It is a prospective, parallel-group, cohort design, multi-center study, which has enrolled 4 groups of pregnant women with epilepsy on AED monotherapy. The results of the NEAD study will improve the health of the children of women taking AEDs and have important applications to the future treatments of women in childbearing age. The specific aims of the Data and Statistical Center (DSC) are to support the coordination of study activities, facilitate data collection through an internet-based data system, and provide statistical and data analysis support in reporting study results.

Products
AdvantageEDC
Services
Data Analysis and Reporting
Project Management
Study Design/Protocol Development
Training and Certification
Web-based Data Collection and Reporting Systems